8-K

a5591644.htm

PFIZER, INC. 8-K

UNITED

STATES

SECURITIES AND

EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT

REPORT

PURSUANT

TO SECTION 13 OR 15 (d) OF THE

SECURITIES

EXCHANGE ACT OF 1934

Date

of Report (Date of earliest event reported): January

23, 2008

PFIZER INC.

(Exact

name of registrant as specified in its charter)

Delaware

1-3619

13-5315170

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

235 East 42nd Street

New York, New York

10017

(Address

of principal executive offices)

(Zip

Code)

Registrant s telephone number, including area code:

(212)

573-2323

Not Applicable

(Former Name or Former Address, if

changed since last report)

Check the

appropriate box below if the Form 8-K filing is intended to

simultaneously satisfy the filing obligation of the registrant under any

of the following provisions:

Written

communications pursuant to Rule 425 under the Securities Act (17 CFR

230.425)

Soliciting

material pursuant to Rule 14a-12 under the Exchange Act (17 CFR

240.14a-12)

Pre-commencement

communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR

240.14d-2(b))

Pre-commencement

communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR

240.13e-4(c))

Item

2.02 Results of Operations and Financial Condition.

On

January 23, 2008, Pfizer Inc. ("Pfizer") issued a press release

announcing its financial results for the fourth quarter of 2007. The

information contained in the press release is deemed to be "filed" under

the Securities Exchange Act of 1934 as Exhibit 99 to this report, and

such press release is incorporated herein by reference.

Item

9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit

99 - Press Release of Pfizer Inc. dated January 23, 2008, reporting

Pfizer's financial results for the fourth quarter of 2007. Exhibit 99 is

deemed to be "filed" under the Securities Exchange Act of 1934 in this

Current Report on Form 8-K.

SIGNATURE

Under the

requirements of the Securities Exchange Act of 1934, the registrant has

duly caused this report to be signed on its behalf by the undersigned

hereunto duly authorized.

PFIZER INC.

By:

/s/ Margaret M. Foran

Margaret M. Foran

Title:

Senior Vice President-Corporate Governance,

Associate General Counsel and Corporate Secretary

Dated:

January 23, 2008

EXHIBIT INDEX

Exhibit No.

Description

99

Press Release of Pfizer Inc. dated January 23, 2008, reporting

Pfizer's financial results for the fourth quarter of 2007.

-->